Givinostat hydrochloride hydrate
| CAS No. | 732302-99-7 |
|---|---|
| MDL No. | MFCD28502062 |
| MF | C24H30ClN3O5 |
| MW | 476.00 |
| InChI Key | FKGKZBBDJSKCIS-UHFFFAOYSA-N |
| CAS No. | 732302-99-7 |
|---|---|
| MDL No. | MFCD28502062 |
| MF | C24H30ClN3O5 |
| MW | 476.00 |
| InChI Key | FKGKZBBDJSKCIS-UHFFFAOYSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Givinostat hydrochloride monohydrate is the monohydrate form of givinostat hydrochloride. It is a histone deacetylase inhibitor indicated for the treatment of Duchenne muscular dystrophy in patients 6 years and older. It functions as an angiogenesis inhibitor, anti-inflammatory agent, antineoplastic agent, apoptosis inducer, and EC 3.5.1.98 (histone deacetylase) inhibitor.
| CAS No. | 732302-99-7 |
|---|---|
| Product Name | Givinostat hydrochloride hydrate |